Leptin administered either systemically or centrally increases sympathetic nerve activity to at least some target tissues (Dunbar et al., 1997; Haynes et al., 1997), and, with chronic administration sufficient to mimic leptin levels seen in obesity, can lead to increases in arterial pressure (Shek et al., 1998). The gene discussed is LEP; the disease is obesity disorder.